In this issue:
Inhibition of SUMOylation promotes remyelination and reduces autoimmune inflammation
Glycine receptor β-targeting autoantibodies contribution to autoimmune pathology
Long-term effects of IL-6 receptor blockade therapy in NMOSD
Cenobamate and clobazam combination as personalised medicine
Impact of early introduction of biologics on internal medications
Safety and efficacy of nipocalimab in patients with gMG
Effect of efgartigimod on muscle group subdomains in gMG
Responder rates with eptinezumab over 24 weeks
Please login below to download this issue (PDF)